Coston McIsaac & Partners Increases Holdings in The Clorox Company (NYSE:CLX)

Coston McIsaac & Partners grew its holdings in shares of The Clorox Company (NYSE:CLX) by 2.5% in the 1st quarter, HoldingsChannel reports. The firm owned 32,702 shares of the company’s stock after acquiring an additional 805 shares during the quarter. Clorox accounts for approximately 1.6% of Coston McIsaac & Partners’ investment portfolio, making the stock its 19th biggest holding. Coston McIsaac & Partners’ holdings in Clorox were worth $5,006,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Choreo LLC increased its holdings in Clorox by 12.8% in the 4th quarter. Choreo LLC now owns 5,741 shares of the company’s stock worth $819,000 after acquiring an additional 652 shares during the last quarter. abrdn plc increased its holdings in Clorox by 20.1% in the 4th quarter. abrdn plc now owns 198,250 shares of the company’s stock worth $28,268,000 after acquiring an additional 33,135 shares during the last quarter. Savoir Faire Capital Management L.P. increased its holdings in Clorox by 61.8% in the 4th quarter. Savoir Faire Capital Management L.P. now owns 65,192 shares of the company’s stock worth $9,296,000 after acquiring an additional 24,897 shares during the last quarter. Banque Cantonale Vaudoise increased its holdings in Clorox by 78.2% in the 1st quarter. Banque Cantonale Vaudoise now owns 29,335 shares of the company’s stock worth $4,492,000 after acquiring an additional 12,872 shares during the last quarter. Finally, Game Plan Financial Advisors LLC purchased a new position in Clorox during the 1st quarter valued at about $1,025,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Price Performance

NYSE:CLX traded down $0.13 during mid-day trading on Friday, reaching $136.47. The stock had a trading volume of 1,667,373 shares, compared to its average volume of 1,254,727. The firm has a 50 day moving average price of $136.95 and a two-hundred day moving average price of $143.80. The stock has a market capitalization of $16.95 billion, a P/E ratio of 70.71, a P/E/G ratio of 2.19 and a beta of 0.39. The Clorox Company has a one year low of $114.68 and a one year high of $169.14. The company has a debt-to-equity ratio of 9.73, a quick ratio of 0.53 and a current ratio of 0.90.

Clorox (NYSE:CLX) last released its earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, topping analysts’ consensus estimates of $1.33 by $0.38. The company had revenue of $1.81 billion during the quarter, compared to the consensus estimate of $1.87 billion. Clorox had a return on equity of 302.49% and a net margin of 3.33%. Clorox’s quarterly revenue was down 5.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.51 EPS. As a group, analysts expect that The Clorox Company will post 5.91 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the company. JPMorgan Chase & Co. reduced their target price on Clorox from $159.00 to $158.00 and set a “neutral” rating for the company in a report on Wednesday, May 1st. Evercore ISI reduced their target price on Clorox from $145.00 to $142.00 and set an “underperform” rating for the company in a report on Wednesday, May 1st. BNP Paribas assumed coverage on Clorox in a report on Monday, June 24th. They set an “underperform” rating and a $130.00 target price for the company. DA Davidson reaffirmed a “neutral” rating and set a $162.00 target price on shares of Clorox in a report on Wednesday, April 17th. Finally, Deutsche Bank Aktiengesellschaft reduced their target price on Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a report on Wednesday, April 17th. Five investment analysts have rated the stock with a sell rating and fourteen have issued a hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $145.33.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.